Table 4 Nuclear expression of β-catenin according to the presence of endometrial cancer, diabetes and method of its treatment
EC - Total | EC DM2 – Metformin | EC DM2 - Insulin or sulfonylurea derivatives | EC – Control group | |
|---|---|---|---|---|
(n = 86) | (n = 32) | (n = 16) | (n = 38) | |
B-CATENIN | 12 (13,9%) | 2 (8,3%) | 2 (12,5%) | 8 (21,5%) |
FIGO | IA- 4 | IA- 1 | IA- 0 | IA- 3 |
IB- 5 | IB- 1 | IB- 2 | IB- 2 | |
II- 1 | II- 0 | II- 0 | II- 1 | |
IIIA- 2 | IIIA- 0 | IIIA- 0 | IIIA- 2 | |
GRADING | G1- 4 | G1- 1 | G1- 1 | G1- 2 |
G2- 5 | G2- 0 | G2- 1 | G2- 4 | |
G3- 3 | G3- 1 | G3- 0 | G3- 2 |